Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Hôpital Beaujon-Pavillon Abrami -Sce Hépatologie, Clichy

Centre Hospitalier Universitaire Grenoble Alpes, Grenoble

Hospital Croix Rousee, Lyon

Hôpital Saint Joseph Hépato-Gastroentérologie, Marseille

CH Pitié-Salpétrière - Hépato-Gastroentérologie, Paris

Hôpital Cochin - Unité d'Hépatologie Pavillon Achard, Paris

"Infectious Clinical Hospital T. Ciorba, Department 4 / Medical University Department of Infectious Diseases", Chisinau

"Infectious Clinical Hospital T. Ciorba, Department 5 / Medical University Department of Infectious Diseases", Chisinau

"Matei Bals National Institute of Infectious Diseases, Hospital department", Bucharest

"Matei Bals National Institute of Infectious Diseases,Clinical Trials department", Bucharest

"Victor Babes Centre of Diagnostic and Treatment", Bucharest

Dr. V. Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest

"State Budgetary Educational Institution of Higher Professional Education South Ural State Medical University of the Ministry of Healthcare of the Russian Federation", Chelyabinsk

Specialized clinical Infectious diseases Hospital, Krasnodar

"Federal Budget Institute of Science Central Research Institute for Epidemiology of Federal Service on Consumers Rights Protection and Human Well-Being Surveillance", Moscow

Federal State Budgetary Institution National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation, Moscow

"LLCClinic of Modern Medicine", Moscow

Moscow Regional Scientific and Research Clinical Institute, Moscow

N.V.Sklifosovsky Scientific Research Institute of Emergency care of the Moscow Healthcare Department, Moscow

"LLC Medical Company Hepatolog", Samara